Discusses Accelerating Generative AI Adoption in Telecom With Purpose-Built Agentic Operating System March 23, 2026 2:00 PM ...
Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results